Regulatory strategy should start the moment you decide to build a medical device—before you lock the intended use, user, setting, claims, or design inputs. Those early […]
Let’s say the quiet part out loud. Most product problems don’t fail inspections because no one cared.They fail because everyone thought the problem was already handled. […]
CAPA Survival Playbooks — Kandih Bioscience FDA expects CAPA, design controls, and risk management to operate as one integrated risk-control system.If CAPA closes without updating design […]
CAPA Survival Playbooks — Kandih Bioscience A CAPA that does not result in a Design History File (DHF) update is not effective in FDA’s eyes.From an […]